Who owns Sutro Biopharma Inc?
- Ticker: STRO
- CUSIP Number: 869367102
Tip: Access positions for across all investors
Analyze quarterly positions in Sutro Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Sutro Biopharma stock
Who bought or sold Sutro Biopharma Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BVF | 3.3M | $14M | 0% | Dec 2023 |
|
Vanguard Group | 2.9M | $12M | 1% | Dec 2023 |
|
Franklin Resources | 2.8M | $12M | -3% | Dec 2023 |
|
Kynam Capital Management | 2.0M | $8.6M | 29% | Dec 2023 |
|
Baillie Gifford & Co | 1.9M | $8.0M | 0% | Dec 2023 |
|
Samsara BioCapital | 1.7M | $7.2M | 0% | Dec 2023 |
|
Millennium Management | 1.5M | $6.6M | 24% | Dec 2023 |
|
Dimensional Fund Advisors | 1.1M | $4.9M | 1% | Dec 2023 |
|
Goldman Sachs Group | 1.1M | $4.5M | -3% | Dec 2023 |
|
Candriam Luxembourg S.C.A. | 898k | $3.9M | -42% | Dec 2023 |
|
Vontobel Holding | 642k | $2.8M | 42% | Dec 2023 |
|
PanAgora Asset Management | 452k | $1.9M | 22% | Dec 2023 |
|
Pentwater Capital Management | 450k | $1.9M | 5% | Dec 2023 |
|
Aquilo Capital Management | 421k | $1.8M | 100% | Dec 2023 |
|
Jacobs Levy Equity Management | 340k | $1.5M | -20% | Dec 2023 |
|
Schonfeld Strategic Advisors | 339k | $1.5M | -5% | Dec 2023 |
|
Two Sigma Investments | 323k | $1.4M | 100% | Dec 2023 |
|
Opaleye Management | 302k | $1.3M | 100% | Dec 2023 |
|
Point72 Asset Management | 286k | $1.2M | -46% | Dec 2023 |
|
DAFNA Capital Management | 283k | $1.2M | 0% | Dec 2023 |
|
Bank of New York Mellon | 263k | $1.1M | 0% | Dec 2023 |
|
Two Sigma Advisers | 240k | $1.0M | 29% | Dec 2023 |
|
Tejara Capital | 227k | $974k | 156% | Dec 2023 |
|
Fisher Investments | 197k | $843k | 0% | Dec 2023 |
|
Propel Bio Management | 195k | $837k | 100% | Dec 2023 |
|
Charles Schwab Investment Management | 161k | $690k | 0% | Dec 2023 |
|
Exome Asset Management | 154k | $659k | 100% | Dec 2023 |
|
Citadel Advisors | 135k | $578k | 166% | Dec 2023 |
|
Barclays | 132k | $566k | 111% | Dec 2023 |
|
Simplify Asset Management | 120k | $515k | 0% | Dec 2023 |
|
Man Group | 119k | $511k | 17% | Dec 2023 |
|
Bank of America Corporation | 111k | $477k | 23% | Dec 2023 |
|
Jane Street | 106k | $453k | 696% | Dec 2023 |
|
Rhumbline Advisers | 92k | $393k | 0% | Dec 2023 |
|
AQR Capital Management | 84k | $359k | 252% | Dec 2023 |
|
Cubist Systematic Strategies | 76k | $327k | 100% | Dec 2023 |
|
Alliancebernstein | 75k | $323k | 0% | Dec 2023 |
|
Walleye Trading Advisors | 73k | $314k | 100% | Dec 2023 |
|
Exchange Traded Concepts | 71k | $402k | 98% | Mar 2024 |
|
Standard Life Aberdeen | 69k | $298k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 66k | $284k | -14% | Dec 2023 |
|
Ohio Pers | 62k | $265k | 0% | Dec 2023 |
|
UBS Group | 60k | $255k | 66% | Dec 2023 |
|
Hsbc Holdings | 52k | $224k | 89% | Dec 2023 |
|
SG Americas Securities | 41k | $175k | 26% | Dec 2023 |
|
Russell Investments | 38k | $164k | -65% | Dec 2023 |
|
CornerCap Investment Counsel | 36k | $153k | 0% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 33k | $140k | -4% | Dec 2023 |
|
State of Wisconsin Investment Board | 30k | $130k | -74% | Dec 2023 |
|
American International | 30k | $128k | 0% | Dec 2023 |
|
Kennedy Capital Management | 30k | $128k | 100% | Dec 2023 |
|
MetLife Investment Advisors | 28k | $122k | 0% | Dec 2023 |
|
Wells Fargo & Company | 23k | $99k | 19% | Dec 2023 |
|
Principal Financial Group | 20k | $85k | -10% | Dec 2023 |
|
Royal Bank of Canada | 19k | $82k | 86% | Dec 2023 |
|
Florida State Board of Administration | 17k | $74k | 0% | Dec 2023 |
|
Virtu Financial | 17k | $72k | 100% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 16k | $70k | -51% | Dec 2023 |
|
T. Rowe Price Associates | 14k | $62k | 10% | Dec 2023 |
|
Squarepoint Ops | 14k | $60k | 100% | Dec 2023 |
|
Dynamic Technology Lab Private | 14k | $60k | 100% | Dec 2023 |
|
New York State Common Retirement Fund | 14k | $59k | -1% | Dec 2023 |
|
Diversified Trust Company | 13k | $74k | 16% | Mar 2024 |
|
Advisor Group Holdings | 10k | $44k | 0% | Dec 2023 |
|
NISA Investment Advisors | 8.8k | $38k | 14126% | Dec 2023 |
|
Citigroup | 8.7k | $37k | 951% | Dec 2023 |
|
Amalgamated Bank | 5.1k | $22k | -10% | Dec 2023 |
|
Summit Investment Advisors | 5.0k | $21k | 0% | Dec 2023 |
|
Legal & General Group | 5.0k | $21k | 0% | Dec 2023 |
|
RidgeWorth Capital Management | 4.4k | $19k | 0% | Dec 2023 |
|
HighMark Wealth Management | 2.3k | $9.7k | 0% | Dec 2023 |
|
Point72 Middle East FZE | 1.8k | $7.7k | 100% | Dec 2023 |
|
Metropolitan Life Insurance Company | 1.1k | $4.7k | -63% | Dec 2023 |
|
Cape Investment Advisory | 1.0k | $4.3k | 100% | Dec 2023 |
|
AdvisorNet Financial | 500.00 | $2.8k | 100% | Mar 2024 |
|
Bogart Wealth | 500.00 | $2.1k | 0% | Dec 2023 |
|
Parallel Advisors | 465.00 | $2.0k | -12% | Dec 2023 |
|
Zurcher Kantonalbank | 285.00 | $1.2k | -87% | Dec 2023 |
|
Federated Investors | 223.00 | $957.004500 | -97% | Dec 2023 |
|
Simplex Trading | 187.00 | $0 | 100% | Dec 2023 |
|
Washington Trust Advisors | 179.00 | $767.999500 | 0% | Dec 2023 |
|
CWM | 47.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Sutro Biopharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Holocene Advisors | Sep 2023 | 2.1M | $7.4M |
Frazier Life Sciences Management | Sep 2023 | 780k | $2.7M |
GSA Capital Partners | Sep 2023 | 68k | $235k |
Mirae Asset Global Investments | Sep 2023 | 45k | $158k |
Virtus Investment Advisers | Sep 2023 | 28k | $98k |
Trexquant Investment | Sep 2023 | 20k | $71k |
Manchester Capital Management | Sep 2023 | 11k | $37k |
China Universal Asset Management | Sep 2023 | 1.5k | $5.0k |
Daiwa Securities Group | Sep 2023 | 158.00 | $999.997800 |